Your browser doesn't support javascript.
loading
APOE2 is associated with longevity independent of Alzheimer's disease.
Shinohara, Mitsuru; Kanekiyo, Takahisa; Tachibana, Masaya; Kurti, Aishe; Shinohara, Motoko; Fu, Yuan; Zhao, Jing; Han, Xianlin; Sullivan, Patrick M; Rebeck, G William; Fryer, John D; Heckman, Michael G; Bu, Guojun.
Afiliação
  • Shinohara M; Department of Neuroscience, Mayo Clinic, Jacksonville, United States.
  • Kanekiyo T; Department of Aging Neurobiology, National Center for Geriatrics and Gerontology, Aichi, Japan.
  • Tachibana M; Department of Neuroscience, Mayo Clinic, Jacksonville, United States.
  • Kurti A; Neuroscience Graduate Program, Mayo Clinic, Jacksonville, United States.
  • Shinohara M; Department of Neuroscience, Mayo Clinic, Jacksonville, United States.
  • Fu Y; United Graduate School of Child Development, Osaka University, Osaka, Japan.
  • Zhao J; Department of Neuroscience, Mayo Clinic, Jacksonville, United States.
  • Han X; Department of Neuroscience, Mayo Clinic, Jacksonville, United States.
  • Sullivan PM; Department of Neuroscience, Mayo Clinic, Jacksonville, United States.
  • Rebeck GW; Department of Neuroscience, Mayo Clinic, Jacksonville, United States.
  • Fryer JD; Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, United States.
  • Heckman MG; Duke University School of Medicine, Durham Veterans Health Administration Medical Center's Geriatric Research, Education and Clinical Center, Durham, United States.
  • Bu G; Department of Neuroscience, Georgetown University Medical Center, Washington, United States.
Elife ; 92020 10 19.
Article em En | MEDLINE | ID: mdl-33074098
ABSTRACT
Although the ε2 allele of apolipoprotein E (APOE2) benefits longevity, its mechanism is not understood. The protective effects of the APOE2 on Alzheimer's disease (AD) risk, particularly through their effects on amyloid or tau accumulation, may confound APOE2 effects on longevity. Herein, we showed that the association between APOE2 and longer lifespan persisted irrespective of AD status, including its neuropathology, by analyzing clinical datasets as well as animal models. Notably, APOE2 was associated with preserved activity during aging, which also associated with lifespan. In animal models, distinct apoE isoform levels, where APOE2 has the highest, were correlated with activity levels, while some forms of cholesterol and triglycerides were associated with apoE and activity levels. These results indicate that APOE2 can contribute to longevity independent of AD. Preserved activity would be an early-observable feature of APOE2-mediated longevity, where higher levels of apoE2 and its-associated lipid metabolism might be involved.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article